Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005 Feb 18;280(7):5892-901. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. Curcumin also impacts aluminum binding to chromatin DNA, which is of relevance. After aluminum mordanting of chicken blood smears, several chelating dyes and reagents were found to detect metal binding to chromatin DNA by fluorescence microscopy. One of them [the reagents] was curcumin. Aluminum is a risk factor for AD.

    References:

    Llorente AR, Del Castillo P, Stockert JC. Aluminium binding to chromatin DNA as revealed by formation of fluorescent complexes with 8-hydroxyquinoline and other ligands. J Microsc. 1989 Aug;155(Pt 2):227-30. PubMed. …More

    View all comments by Erik Jansson

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Curry Ingredient Spices Things Up by Blocking Aβ Aggregation
  2. We Are What We Consume? Foods, Drugs Affect Amyloid, AD
  3. San Francisco: Tau—Time to Shine as Therapeutic Target?
  4. EU Consortium Applies Nanotechnology to Study AD
  5. One Small Molecule Detoxifies Different Forms of Aβ
  6. Dyeing Worms for an Extra-Long, Healthy Lifespan?
  7. Does New Take on Old Spice Refresh Approach to AD Treatment?

Therapeutics

  1. Curcumin
AlzAntibodiesAlzBiomarkerAlzRiskBrain BanksGeneticsAlzGeneHEXMutationsProtocolsResearch ModelsTherapeutics